Acetoacetic acid (lithium)
Acetoacetic acid lithium is an oxidative stress inducer that affects the antioxidant enzyme system and lipoprotein metabolism. Acetoacetic acid lithium induces oxidative stress by decreasing the mRNA expression and activity of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px), increasing MDA content, and inhibiting very low density lipoprotein (VLDL) assembly by downregulating apolipoprotein ApoB100, ApoE, and low density lipoprotein receptor (LDLR), leading to triglyceride (TG) accumulation in hepatocytes. Acetoacetic acid lithium can be used to study metabolic diseases[1][2][3].
Product Specifications
CAS Number
[3483-11-2]
UNSPSC
12352211
Hazard Statement
H315, H319, H335
Target
Endogenous Metabolite
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/acetoacetic-acid-lithium.html
Purity
98.0
Solubility
DMSO : 1.54 mg/mL (ultrasonic; warming; heat to 60°C) |H2O : 100 mg/mL (ultrasonic)
Smiles
CC(CC(O[Li])=O)=O
Molecular Formula
C4H5LiO3
Molecular Weight
108.02
Precautions
H315, H319, H335
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
Human Endogenous Metabolite
Available Sizes
Explore Other Products
Browse additional items from our catalog
Human MMR/CD206 Alexa Fluor 647 Antibody (Clone 685641)
NMES1 (C15orf48) (NM_032413) Human Over-expression Lysate
FKBP14, CT (FKBP14, FKBP22, Peptidyl-prolyl cis-trans isomerase FKBP14, 22kD FK506-binding protein, FK506-binding protein 14, Rotamase) (PE)
FKBP14, CT (FKBP14, FKBP22, Peptidyl-prolyl cis-trans isomerase FKBP14, 22kD FK506-binding protein, FK506-binding protein 14, Rotamase) (PE)